Monday, April 28, 2025

Latest

Starbucks: Analyst Consensus Estimates

Starbucks (NASDAQ: SBUX) will be reporting their fiscal second quarter financial results today after the close of markets. Analysts have a consensus $115.05 12-month price target on the company, via a total of 34 analysts, with ten analysts having strong buy ratings. Nine analysts meanwhile have buy ratings and 15 have hold ratings. The street high is a $137 price target, and the lowest target sits at $82.

24 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 24 analysts is $6.8 billion; this number has been revised upwards from $6.7 billion at the start of the year. The highest revenue estimate is $7.47 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently 17 analysts who have second-quarter EBITDA estimates. The mean is currently $1.27 billion, with this number having been revised down from $1.35 billion at the start of the year. The street high estimate currently sits at $1.36 billion in EBITDA and the lowest is $1.17 billion.

Analysts estimate that quarterly earnings per share will come in at $0.52, with this number being slightly revised down from $0.59 at the start of the year. Street high currently sits at $0.59 in earnings per share, while the lowest estimate is $0.47 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Medipharm Labs Sees Canaccord Drop Price Target To $0.75

On May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced...

Tuesday, May 18, 2021, 05:32:00 PM

BMO Capital Markets Initiates Coverage On Multiple Oilfield Servicing Firms

This week, BMO initiated coverage on several large-cap U.S oilfield services. BMO’s Phillip Jungwirth commented...

Friday, October 2, 2020, 02:39:00 PM

Equinox Gold: Haywood Slashes Targets After Poor Q2 Performance

Equinox Gold Corp. (TSX: EQX) last week reported its second quarter financial results. The company...

Monday, August 8, 2022, 03:49:00 PM

Cresco Labs: Canaccord Cuts Price Target On Muted Growth, Pricing Challenges

On August 17, Cresco Labs (CSE: CL) reported its second quarter financial results. The company...

Friday, August 19, 2022, 02:12:00 PM

Senate Goes Blue: The Cannabis Analyst Take

Two days ago, Georgia had its senate runoffs to effectively decide which party would have...

Thursday, January 7, 2021, 11:51:00 AM